HIV/AIDS - Research and Palliative Care
Incidence and Predictors of Hyperglycemia Among Adults Receiving Dolutegravir-Based Antiretroviral Therapy at Mbarara Regional Referral Hospital HIV Clinic, Uganda: A Retrospective Cohort Study
Par Arinaitwe Medard, Geoffrey Mwesigwa, Derrick Asiimwe et 3 autres.
Contenu en anglais
Résumé
Background
Dolutegravir (DTG)-based antiretroviral therapy is widely used in sub-Saharan Africa, but routine-care evidence on incident hyperglycemia after DTG initiation or substitution remains limited in southwestern Uganda.